DENMARK Trends and Developments Contributed by: Poul Guo, Martin Søndergaard, Patricia Rasch and Jonas Miller Rasmussen, Moalem Weitemeyer
sciences. Additionally, the limited availability of resources – such as office space and advanced research facilities – can further strain the growth potential of emerging companies. Despite these challenges, Denmark’s emphasis on health tech and green innovation provides a robust foundation for sustained growth in the VC market. With the implementation of several gov - ernment initiatives and policy reforms aimed at fostering innovation and supporting start-ups in these sectors, the future appears bright. Health tech, in particular, has seen significant investment activity, with companies such as Again and Cerebriu raising substantial capital in recent quarters. These investments reflect the growing demand for innovative healthcare solutions that can improve patient outcomes and reduce healthcare costs. Denmark’s strong healthcare infrastructure and the collaborative ecosystem between academia, industry and government create an ideal environment for health tech start-ups to thrive. Similarly, green innovation has gained considera - ble traction, with green VC investments reaching record highs. In the first three quarters of 2024, green businesses in Denmark attracted DKK1.7 billion in VC – a 26% increase compared to the previous year. This growth is driven by the global shift towards sustainability and the increasing importance of environmentally friendly business models. Danish companies such as Stiesdal, which focus on cleantech solutions, are at the forefront of this movement, attracting significant investment and reinforcing Denmark’s reputation as a leader in green innovation. Conclusion The Danish VC market’s experience in 2024 served as a microcosm of the broader chal -
lenges faced by start-ups and investors during periods of economic and geopolitical uncer - tainty. The significant decline in invested capital – despite a stable number of investment rounds – highlights the cautious approach adopted by investors under such conditions. For start-ups, this environment can be particu - larly challenging. Securing funding becomes more difficult as investors grow increasingly risk-averse, preferring to allocate capital to safer, more established ventures or sectors perceived as more resilient. This can stifle innovation and growth, as early-stage companies struggle to access the financial support required to develop products, scale operations and bring new tech - nologies to market. Initiatives such as Match - loans have played a valuable role in strength - ening early-stage start-ups by providing crucial non-dilutive funding and bridging the gap in an otherwise risk-averse investment climate. However, the continued investment in the life sciences and cleantech sectors during Q3 2024 demonstrates that even in uncertain times there are areas of the market capable of attracting sig - nificant capital. These sectors are often viewed as having strong long-term growth potential and the capacity to address critical global chal - lenges, such as healthcare advancements and environmental sustainability. Investors may con - sider these sectors more resilient to economic fluctuations and geopolitical tensions, making them attractive options for capital allocation. At the same time, the decline in exit opportu - nities – particularly through IPOs – has made it more difficult for investors to realise returns, resulting in a growing reliance on M&A activity and secondary sales. Additionally, increased FDI screening has introduced further regulatory complexity for foreign investors, especially those
163 CHAMBERS.COM
Powered by FlippingBook